Mathematical modeling of a continuous-flow packed-bed reactor with immobilized lipase for kinetic resolution of (R,S)-2-pentanol

por SOYER MALYEMEZ, Aslı, GIWA, Abdulwahab, BAYRAKTAR, Emine, MEHMETOĞLU, Ülkü
Publicado 2020

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update

por Bayraktar, Emine, Bayraktar, Recep, Oztatlici, Hulya, Lopez-Berestein, Gabriel, Amero, Paola, Rodriguez-Aguayo, Cristian
Publicado 2023

Exosomes: From Garbage Bins to Promising Therapeutic Targets

por H. Rashed, Mohammed, Bayraktar, Emine, K. Helal, Gouda, Abd-Ellah, Mohamed F., Amero, Paola, Chavez-Reyes, Arturo, Rodriguez-Aguayo, Cristian
Publicado 2017

Correction: MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

por Bayraktar, Recep, Pichler, Martin, Kanlikilicer, Pinar, Ivan, Cristina, Bayraktar, Emine, Kahraman, Nermin, Aslan, Burcu, Oguztuzun, Serpil, Ulasli, Mustafa, Arslan, Ahmet, Calin, George, Lopez-Berestein, Gabriel, Ozpolat, Bulent
Publicado 2023

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

por Bayraktar, Recep, Pichler, Martin, Kanlikilicer, Pinar, Ivan, Cristina, Bayraktar, Emine, Kahraman, Nermin, Aslan, Burcu, Oguztuzun, Serpil, Ulasli, Mustafa, Arslan, Ahmet, Calin, George, Lopez-Berestein, Gabriel, Ozpolat, Bulent
Publicado 2016

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway

por Elsayed, Abdelrahman M., Bayraktar, Emine, Amero, Paola, Salama, Salama A., Abdelaziz, Abdelaziz H., Ismail, Raed S., Zhang, Xinna, Ivan, Cristina, Sood, Anil K., Lopez-Berestein, Gabriel, Rodriguez-Aguayo, Cristian
Publicado 2021

Targeting CCR2(+) macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer

por Wu, Yutuan, Jennings, Nicholas B., Sun, Yunjie, Dasari, Santosh K., Bayraktar, Emine, Corvigno, Sara, Stur, Elaine, Glassman, Deanna, Mangala, Lingegowda S., Lankenau Ahumada, Adrian, Westin, Shannon N., Sood, Anil K., Hu, Wei
Publicado 2022

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy

por Gao, Chao, Jin, Guangxu, Forbes, Elizabeth, Mangala, Lingegowda S., Wang, Yingmei, Rodriguez-Aguayo, Cristian, Amero, Paola, Bayraktar, Emine, Yan, Ye, Lopez-Berestein, Gabriel, Broaddus, Russell R., Sood, Anil K., Xue, Fengxia, Zhang, Wei
Publicado 2021

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer

por Lara, Olivia D., Bayraktar, Emine, Amero, Paola, Ma, Shaolin, Ivan, Cristina, Hu, Wei, Wang, Ying, Mangala, Lingegowda S., Dutta, Prasanta, Bhattacharya, Pratip, Ashizawa, Ana Tari, Lopez-Berestein, Gabriel, Rodriguez-Aguayo, Cristian, Sood, Anil K.
Publicado 2020

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer

por Gorur, Aysegul, Bayraktar, Recep, Ivan, Cristina, Mokhlis, Hamada Ahmed, Bayraktar, Emine, Kahraman, Nermin, Karakas, Didem, Karamil, Selda, Kabil, Nashwa N., Kanlikilicer, Pinar, Aslan, Burcu, Tamer, Lulufer, Wang, Zhihui, Cristini, Vittorio, Lopez-Berestein, Gabriel, Calin, George, Ozpolat, Bulent
Publicado 2021

Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer

por Rodriguez-Aguayo, Cristian, del C Monroig, Paloma, Redis, Roxana S., Bayraktar, Emine, Almeida, Maria I., Ivan, Cristina, Fuentes-Mattei, Enrique, Rashed, Mohammed H., Chavez-Reyes, Arturo, Ozpolat, Bulent, Mitra, Rahul, Sood, Anil K., Calin, George A., Lopez-Berestein, Gabriel
Publicado 2023

Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer

por Rodriguez-Aguayo, Cristian, Monroig, Paloma del C, Redis, Roxana S, Bayraktar, Emine, Almeida, Maria I, Ivan, Cristina, Fuentes-Mattei, Enrique, Rashed, Mohammed H, Chavez-Reyes, Arturo, Ozpolat, Bulent, Mitra, Rahul, Sood, Anil K, Calin, George A, Lopez-Berestein, Gabriel
Publicado 2017

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

por Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2019

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-...

por Rodriguez-Aguayo, Cristian, Bayraktar, Emine, Ivan, Cristina, Aslan, Burcu, Mai, Junhua, He, Guangan, Mangala, Lingegowda S., Jiang, Dahai, Nagaraja, Archana S., Ozpolat, Bulent, Chavez-Reyes, Arturo, Ferrari, Mauro, Mitra, Rahul, Siddik, Zahid H., Shen, Haifa, Yang, Xianbin, Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2022

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer

por Dasari, Santosh K., Joseph, Robiya, Umamaheswaran, Sujanitha, Mangala, Lingegowda S., Bayraktar, Emine, Rodriguez-Aguayo, Cristian, Wu, Yutuan, Nguyen, Nghi, Powell, Reid T., Sobieski, Mary, Liu, Yuan, Chowdhury, Mamur A., Amero, Paola, Stephan, Clifford, Lopez-Berestein, Gabriel, Westin, Shannon N., Sood, Anil K.
Publicado 2023

Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype

por Ma, Shaolin, McGuire, Michael H., Mangala, Lingegowda S., Lee, Sanghoon, Stur, Elaine, Hu, Wen, Bayraktar, Emine, Villar-Prados, Alejandro, Ivan, Cristina, Wu, Sherry Y., Yokoi, Akira, Dasari, Santosh K., Jennings, Nicholas B., Liu, Jinsong, Lopez-Berestein, Gabriel, Ram, Prahlad, Sood, Anil K.
Publicado 2021

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

por Rashed, Mohammed H, Kanlikilicer, Pinar, Rodriguez-Aguayo, Cristian, Pichler, Martin, Bayraktar, Recep, Bayraktar, Emine, Ivan, Cristina, Filant, Justyna, Silva, Andreia, Aslan, Burcu, Denizli, Merve, Mitra, Rahul, Ozpolat, Bulent, Calin, George A., Sood, Anil K., Abd-Ellah, Mohamed F., Helal, Gouda K., Berestein, Gabriel Lopez
Publicado 2017

Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma

por Stur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y., Mangala, Lingegowda S., Yao, Hui, Wang, Ying, Ram, Prahlad T., Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S., Levine, Douglas A., Lutgendorf, Susan K., Liu, Jinsong, Moore, Kathleen N., Baggerly, Keith A., Karlan, Beth Y., Sood, Anil K.
Publicado 2022

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

por Kanlikilicer, Pinar, Bayraktar, Recep, Denizli, Merve, Rashed, Mohammed H., Ivan, Cristina, Aslan, Burcu, Mitra, Rahul, Karagoz, Kubra, Bayraktar, Emine, Zhang, Xinna, Rodriguez-Aguayo, Cristian, El-Arabey, Amr Ahmed, Kahraman, Nermin, Baydogan, Seyda, Ozkayar, Ozgur, Gatza, Michael L., Ozpolat, Bulent, Calin, George A., Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2018

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112]

por Kanlikilicer, Pinar, Bayraktar, Recep, Denizli, Merve, Rashed, Mohammed H., Ivan, Cristina, Aslan, Burcu, Mitra, Rahul, Karagoz, Kubra, Bayraktar, Emine, Zhang, Xinna, Rodriguez-Aguayo, Cristian, El-Arabey, Amr Ahmed, Kahraman, Nermin, Baydogan, Seyda, Ozkayar, Ozgur, Gatza, Michael L., Ozpolat, Bulent, Calin, George A., Sood, Anil K., Lopez-Berestein, Gabriel
Publicado 2020